documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
22 rows where docket_id = "FDA-1980-N-0049" and posted_year = 2003 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: title, posted_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1980-N-0049-0067 | FDA | Biological Products; Bacterial Vaccines & Toxiods FDA-1980-N-0049 | Reference 19: http://www.fda.gov/cber/gdlns/leverhnbk.pdf | Supporting & Related Material | Background Material | 2003-12-29T05:00:00Z | 2003 | 12 | 2020-05-19T17:42:07Z | 0 | 0 | 09000064805b99cb | |||
| FDA-1980-N-0049-0077 | FDA | Biological Products; Bacterial Vaccines & Toxiods FDA-1980-N-0049 | Reference 12: "Protecting our Kids: What is causing the current shortage in childhood vaccines? Testimony Before the Committee on Governmental Affairs, United States Senate," June 12, 2002," http://www. cdc.gov/nip/news/testimonies/vac-shortages-walt-6-12-2002. htm | Supporting & Related Material | Background Material | 2003-12-29T05:00:00Z | 2003 | 12 | 2020-05-19T18:58:35Z | 0 | 0 | 09000064805b99d5 | |||
| FDA-1980-N-0049-0065 | FDA | Biological Products; Bacterial Vaccines & Toxiods FDA-1980-N-0049 | Reference 18: http://www.fda.gov/ohrms//dockets/ac/02/transcripts/3842t1.pdf | Supporting & Related Material | Background Material | 2003-12-29T05:00:00Z | 2003 | 12 | 2020-05-19T17:53:55Z | 0 | 0 | 09000064805b99c9 | |||
| FDA-1980-N-0049-0068 | FDA | Biological Products; Bacterial Vaccines & Toxiods FDA-1980-N-0049 | Reference 16: http://www.fda. gov/ohrms/dockets/ac/01/transcripts/3805t2_01 .pdf | Supporting & Related Material | Background Material | 2003-12-29T05:00:00Z | 2003 | 12 | 2020-05-19T17:31:09Z | 0 | 0 | 09000064805b99cc | |||
| FDA-1980-N-0049-0074 | FDA | Biological Products; Bacterial Vaccines & Toxiods FDA-1980-N-0049 | Reference 6: Anthrax Vaccine Adsorbed (BIOTHRAX) Package Insert (January 31, 2002) | Supporting & Related Material | Background Material | 2003-12-29T05:00:00Z | 2003 | 12 | 2020-05-19T16:51:25Z | 0 | 0 | 09000064805b99d2 | |||
| FDA-1980-N-0049-0079 | FDA | Biological Products; Bacterial Vaccines & Toxiods FDA-1980-N-0049 | Reference List | Supporting & Related Material | Background Material | 2003-12-29T05:00:00Z | 2003 | 12 | 2020-05-19T16:09:59Z | 0 | 0 | 09000064805b99d7 | |||
| FDA-1980-N-0049-0080 | FDA | Biological Products; Bacterial Vaccines & Toxiods FDA-1980-N-0049 | Reference 14: Centers for Disease Control and Prevention,"Prevention of Plague: Recommendations of the Advisory Committee on Immunization Practices (ACIP)," Morbidity and Mortality Weekly Report, 45 (No. RR-14), 1996 | Supporting & Related Material | Background Material | 2003-12-29T05:00:00Z | 2003 | 12 | 2020-05-19T18:49:26Z | 0 | 0 | 09000064805b99d8 | |||
| FDA-1980-N-0049-0070 | FDA | Biological Products; Bacterial Vaccines & Toxiods FDA-1980-N-0049 | Reference 10: "Guidance for Industry: How to Complete the Vaccine Adverse Event Reporting System Form (VAERS-1)," September 1998, http://www.fda.gov/cber/gdlns/vaers-1.pdf | Supporting & Related Material | Background Material | 2003-12-29T05:00:00Z | 2003 | 12 | 2020-05-19T17:17:27Z | 0 | 0 | 09000064805b99ce | |||
| FDA-1980-N-0049-0084 | FDA | Biological Products; Bacterial Vaccines & Toxiods FDA-1980-N-0049 | Reference 2: Lois M. Joellenbeck, Lee L. Zwanziger, Jane S. Durch, and Brian L. Strom, Editors, Committee to Assess the Safety and Efficacy of the Anthrax Vaccine, Medical Follow-Up Agency, The National Academies Press, Washington, DC, http://www. nap. edu/catalog/10310. html. | Supporting & Related Material | Background Material | 2003-12-29T05:00:00Z | 2003 | 12 | 2020-05-19T19:30:18Z | 0 | 0 | 09000064805b99dc | |||
| FDA-1980-N-0049-0063 | FDA | Biological Products; Bacterial Vaccines & Toxiods FDA-1980-N-0049 | Reference 11: "Estimated Vaccination Coverage with 3+DTP Among Children 19-35 Months of Age by Race/Ethnicity, and by State and Immunization Action Plan Area - U.S., National Immunization Survey, Q3/2000 - Q2/2001," http://www.cdc.gov/nip/coverage/NlS/00-01/tab19- 3dpt_race_iap. htm. | Supporting & Related Material | Background Material | 2003-12-29T05:00:00Z | 2003 | 12 | 2020-05-19T19:21:05Z | 0 | 0 | 09000064805b99c7 | |||
| FDA-1980-N-0049-0076 | FDA | Biological Products; Bacterial Vaccines & Toxiods FDA-1980-N-0049 | Reference 2: Lois M. Joellenbeck, Lee L. Zwanziger, Jane S. Durch, and Brian L. Strom, Editors, Committee to Assess the Safety and Efficacy of the Anthrax Vaccine, Medical Follow-Up Agency, The National Academies Press, Washington, DC, http://www. nap. edu/catalog/10310. html. | Supporting & Related Material | Background Material | 2003-12-29T05:00:00Z | 2003 | 12 | 2020-05-19T16:40:29Z | 0 | 0 | 09000064805b99d4 | |||
| FDA-1980-N-0049-0083 | FDA | Biological Products; Bacterial Vaccines & Toxiods FDA-1980-N-0049 | Reference 3: Fellows, P. F., M. K. Linscott, B. E. Ivins, M. L. M. Pitt, C. A. Rossi, P. H. Gibbs, and A. M. Friedlander, "Efficacy of a Human Anthrax Vaccine in Guinea Pigs, Rabbits, and Rhesus Macaques Against Challenge by Bacillus Anthracis Isolates of Diverse Geographical Origin," Vaccine, 19(23-24):3241-3247, 2001 | Supporting & Related Material | Background Material | 2003-12-29T05:00:00Z | 2003 | 12 | 2020-05-19T18:23:42Z | 0 | 0 | 09000064805b99db | |||
| FDA-1980-N-0049-0081 | FDA | Biological Products; Bacterial Vaccines & Toxiods FDA-1980-N-0049 | Reference 2: Lois M. Joellenbeck, Lee L. Zwanziger, Jane S. Durch, and Brian L. Strom, Editors, Committee to Assess the Safety and Efficacy of the Anthrax Vaccine, Medical Follow-Up Agency, The National Academies Press, Washington, DC, http://www. nap. edu/catalog/10310. html. | Supporting & Related Material | Background Material | 2003-12-29T05:00:00Z | 2003 | 12 | 2020-05-19T16:41:44Z | 0 | 0 | 09000064805b99d9 | |||
| FDA-1980-N-0049-0082 | FDA | Biological Products; Bacterial Vaccines & Toxiods FDA-1980-N-0049 | Reference 4: Ivins, B. E., P. F. Fellows, M. L. M. Pitt, J. E. Estep, S. L. Welkos, P. L.Worsham and A. M. Friedlander, "Efficacy of a Standard Human Anthrax Vaccine Against Bacillus Anthracis Aerosol Spore Challenge in Rhesus Monkeys," Salisbury Medical Bulletin 87(Suppl.):125-126, 1996 | Supporting & Related Material | Background Material | 2003-12-29T05:00:00Z | 2003 | 12 | 2020-05-19T18:30:13Z | 0 | 0 | 09000064805b99da | |||
| FDA-1980-N-0049-0073 | FDA | Biological Products; Bacterial Vaccines & Toxiods FDA-1980-N-0049 | Reference 7: Wright, G. G., Green, T. W, and Kanode, Jr., R. G., "Studies on Immunity in Anthrax: V. Immunizing Activity of Alum-Precipitated Protective Antigen," Journal of Immunology, 73:387- 391, 1954 | Supporting & Related Material | Background Material | 2003-12-29T05:00:00Z | 2003 | 12 | 2020-05-19T16:57:23Z | 0 | 0 | 09000064805b99d1 | |||
| FDA-1980-N-0049-0075 | FDA | Biological Products; Bacterial Vaccines & Toxiods FDA-1980-N-0049 | Reference 1: Brachman, P. S., H. Gold, S. Plotkin, F. R. Fekety, M. Werrin, and N. R. Ingraham, "Field Evaluation of a Human Anthrax Vaccine," American Journal of Public Health, 52:632-645, 1962. | Supporting & Related Material | Background Material | 2003-12-29T05:00:00Z | 2003 | 12 | 2020-05-19T16:42:28Z | 0 | 0 | 09000064805b99d3 | |||
| FDA-1980-N-0049-0064 | FDA | Biological Products; Bacterial Vaccines & Toxiods FDA-1980-N-0049 | Reference 9: "Table of Reportable Events Following Vaccination," http://www.vaers.org/reportable.htm. | Supporting & Related Material | Background Material | 2003-12-29T05:00:00Z | 2003 | 12 | 2020-05-19T19:11:53Z | 0 | 0 | 09000064805b99c8 | |||
| FDA-1980-N-0049-0071 | FDA | Biological Products; Bacterial Vaccines & Toxiods FDA-1980-N-0049 | Reference 13: Colditz, et al., "Efficacy of BCG Vaccine in the Prevention of Tuberculosis: Meta Analysis of the Published Literature," Journal of the American Medical Association, 271:698-702, 1994 | Supporting & Related Material | Background Material | 2003-12-29T05:00:00Z | 2003 | 12 | 2020-05-19T17:09:06Z | 0 | 0 | 09000064805b99cf | |||
| FDA-1980-N-0049-0066 | FDA | Biological Products; Bacterial Vaccines & Toxiods FDA-1980-N-0049 | Transcript in the matter of Vaccines and Related Biological Products Advisory Committee | Supporting & Related Material | Background Material | 2003-12-29T05:00:00Z | 2003 | 12 | 2020-05-20T16:17:24Z | 0 | 0 | 09000064805b99ca | |||
| FDA-1980-N-0049-0069 | FDA | Biological Products; Bacterial Vaccines & Toxiods FDA-1980-N-0049 | Reference 15: http://Mrww.fda.gov/ohrms/dockets/ac/01/transcripts/3755t1.pdf | Supporting & Related Material | Background Material | 2003-12-29T05:00:00Z | 2003 | 12 | 2020-05-19T17:26:38Z | 0 | 0 | 09000064805b99cd | |||
| FDA-1980-N-0049-0078 | FDA | Biological Products; Bacterial Vaccines & Toxiods FDA-1980-N-0049 | Reference 5: Ivins, B. E., M. L. M. Pitt, P. F. Fellows, J. W. Farchaus, B. E. Benner, D. M. Waag, S. F. Little, G. W. Anderson, P. H. Gibbs, and A. M. Friedlander, "Comparative Efficacy of Experimental Anthrax Vaccine Candidates Against Inhalation Anthrax in Rhesus Macaques," Vaccine, 16(11-12):1141-1148,1998 | Supporting & Related Material | Background Material | 2003-12-29T05:00:00Z | 2003 | 12 | 2020-05-19T18:42:51Z | 0 | 0 | 09000064805b99d6 | |||
| FDA-1980-N-0049-0072 | FDA | Biological Products; Bacterial Vaccines & Toxiods FDA-1980-N-0049 | Reference 8: 61 FR 40153, August 1, 1996 | Supporting & Related Material | Background Material | 2003-12-29T05:00:00Z | 2003 | 12 | 2020-05-19T17:01:43Z | 0 | 0 | 09000064805b99d0 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);